Avanir raises $88M following Nuedexta approval

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) raised $88 million through the sale of 20 million shares at $4.40 per share in a follow-on underwritten by Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman. The company proposed the offer on Tuesday, when its stock price was $4.62. Trout Capital advised Avanir. ...